Aclaris Therapeutics, Inc. ACRS

Set alert

3.74 USD -0.06 (-1.58%)

At closeNov 4, 2026, 4:00 AM EST

3.86 +0.12 +3.21%

Pre-market · Nov 4, 4:00 AM ET

3.67 Day range 3.94

2.10 52-week range 6.60

Held by insiders 3.65%

Held by institutions 90.21%

Float held by institutions 93.63%

Institutions 107

Top institutional holders
Holder	% held	Shares	Value	Reported
BML Capital Management, LLC	13.32%	14,250,000	41.33M	Sep 29, 2024
Vanguard Group Inc	4.38%	4,685,498	13.59M	Sep 29, 2024
Shaw D.E. & Co., Inc.	3.15%	3,371,849	9.78M	Sep 29, 2024
Millennium Management Llc	2.81%	3,005,598	8.72M	Sep 29, 2024
Rock Springs Capital Management, LP	2.57%	2,753,495	7.99M	Sep 29, 2024
Stonepine Capital Management, LLC	2.30%	2,458,873	7.13M	Sep 29, 2024

Top mutual fund holders
Holder	% held	Shares	Value	Reported
Vanguard Total Stock Market Index Fund	1.98%	2,115,428	6.13M	Sep 29, 2024
Vanguard Extended Market Index Fund	0.77%	820,732	2.38M	Sep 29, 2024
Vanguard Horizon Fund-Strategic Small-Cap Equity Fund	0.66%	706,504	2.05M	Sep 29, 2024
Vanguard Variable Insurance Fund-Small Company Growth	0.60%	639,021	1.85M	Sep 29, 2024
iShares Biotechnology ETF	0.46%	491,473	1.43M	Oct 30, 2024
Fidelity Extended Market Index Fund	0.38%	403,786	1.17M	Oct 30, 2024

ACRS insiders
Insider	Relation	Latest transaction	Date	Shares held
BALTHASER KEVIN J	Chief Financial Officer	Conversion of Exercise of derivative security	Aug 29, 2024	24,697
HUMPHRIES WILLIAM DOUGLAS	Director	Conversion of Exercise of derivative security	May 30, 2024	28,732
LEONARD BRADEN MICHAEL	Beneficial Owner of more than 10% of a Class of Security	Purchase	Aug 4, 2024	0
MEHRA ANAND	Director	Purchase	Nov 18, 2024	710,030
MILANO VINCENT J	Director	Conversion of Exercise of derivative security	May 30, 2024	12,523
MOLINEAUX CHRISTOPHER P	Director	Conversion of Exercise of derivative security	May 30, 2024	53,163

Held by funds